Trial intelligence / Profile preview

Maraviroc for microbial translocation in treated HIV infection

ISRCTN81045654Phase 4Completed

Sponsor
Guy's and St Thomas' NHS Foundation Trust
Start
Sep 2011
Modality
Small Molecules
01

Overview

Phase 4, open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Soluble CD14 level. Started Sep 2011; status: completed.

02

Drugs

maraviroc
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on ISRCTN81045654.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN81045654.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call